Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Apr;39(4):854–858. doi: 10.1128/aac.39.4.854

Evaluation of maduramicin and alborixin in a SCID mouse model of chronic cryptosporidiosis.

J R Mead 1, X You 1, J E Pharr 1, Y Belenkaya 1, M J Arrowood 1, M T Fallon 1, R F Schinazi 1
PMCID: PMC162642  PMID: 7785984

Abstract

Two polyether ionophores, maduramicin and alborixin, were evaluated for anticryptosporidial activity in a severe combined immune deficient (SCID) mouse model of cryptosporidiosis. Groups of SCID mice were inoculated with 10(6) oocysts of bovine origin by oral gavage. Maduramicin or alborixin was administered beginning 4 weeks postinfection at 3 mg/kg of body weight per day. Maduramicin treatment resulted in a 96% reduction in fecal parasite load over the 3-week treatment period (P < 0.003). This reduction correlated with decreases in tissue parasite loads observed in histological sections of the small intestine (P < 0.000002) and the colon (P < 0.000006). A significant decrease in oocyst shedding was also observed after a 3-week treatment with alborixin (71% reduction, P < 0.01). Maduramicin was also evaluated in a relapsing model of cryptosporidiosis in which the infection was observed to recur after treatments were discontinued. Some toxicity, as demonstrated by weight loss, was observed with both maduramicin and alborixin. Both drugs exhibited significant anticryptosporidial activities with concomitant moderate toxicity. These polyether ionophores should be valuable as positive controls in compound evaluation studies and as lead compounds for chemical optimization (modification).

Full Text

The Full Text of this article is available as a PDF (243.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arrowood M. J., Sterling C. R. Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic Percoll gradients. J Parasitol. 1987 Apr;73(2):314–319. [PubMed] [Google Scholar]
  2. Arrowood M. J., Xie L. T., Hurd M. R. In vitro assays of maduramicin activity against Cryptosporidium parvum. J Eukaryot Microbiol. 1994 Sep-Oct;41(5):23S–23S. [PubMed] [Google Scholar]
  3. Blagburn B. L., Sundermann C. A., Lindsay D. S., Hall J. E., Tidwell R. R. Inhibition of Cryptosporidium parvum in neonatal Hsd:(ICR)BR Swiss miceby polyether ionophores and aromatic amidines. Antimicrob Agents Chemother. 1991 Jul;35(7):1520–1523. doi: 10.1128/aac.35.7.1520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brasseur P., Lemeteil D., Ballet J. J. Rat model for human cryptosporidiosis. J Clin Microbiol. 1988 May;26(5):1037–1039. doi: 10.1128/jcm.26.5.1037-1039.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ernest J. A., Blagburn B. L., Lindsay D. S., Current W. L. Infection dynamics of Cryptosporidium parvum (Apicomplexa: Cryptosporiidae) in neonatal mice (Mus musculus). J Parasitol. 1986 Oct;72(5):796–798. [PubMed] [Google Scholar]
  6. Flanigan T. P. Human immunodeficiency virus infection and cryptosporidiosis: protective immune responses. Am J Trop Med Hyg. 1994;50(5 Suppl):29–35. [PubMed] [Google Scholar]
  7. Flanigan T. P., Soave R. Cryptosporidiosis. Prog Clin Parasitol. 1993;3:1–20. doi: 10.1007/978-1-4612-2732-8_1. [DOI] [PubMed] [Google Scholar]
  8. Heine J., Moon H. W., Woodmansee D. B. Persistent Cryptosporidium infection in congenitally athymic (nude) mice. Infect Immun. 1984 Mar;43(3):856–859. doi: 10.1128/iai.43.3.856-859.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kuhls T. L., Greenfield R. A., Mosier D. A., Crawford D. L., Joyce W. A. Cryptosporidiosis in adult and neonatal mice with severe combined immunodeficiency. J Comp Pathol. 1992 May;106(4):399–410. doi: 10.1016/0021-9975(92)90024-o. [DOI] [PubMed] [Google Scholar]
  10. Leitch G. J., He Q. Putative anticryptosporidial agents tested with an immunodeficient mouse model. Antimicrob Agents Chemother. 1994 Apr;38(4):865–867. doi: 10.1128/aac.38.4.865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Long P. L., Millard B. J. Eimeria: effect of meticlorpindol and methyl benzoquate on endogenous stages in the chicken. Exp Parasitol. 1968 Dec;23(3):331–338. doi: 10.1016/0014-4894(68)90025-8. [DOI] [PubMed] [Google Scholar]
  12. McDonald V., Stables R., Warhurst D. C., Barer M. R., Blewett D. A., Chapman H. D., Connolly G. M., Chiodini P. L., McAdam K. P. In vitro cultivation of Cryptosporidium parvum and screening for anticryptosporidial drugs. Antimicrob Agents Chemother. 1990 Aug;34(8):1498–1500. doi: 10.1128/aac.34.8.1498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mead J. R., Arrowood M. J., Sidwell R. W., Healey M. C. Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice. J Infect Dis. 1991 Jun;163(6):1297–1304. doi: 10.1093/infdis/163.6.1297. [DOI] [PubMed] [Google Scholar]
  14. Mead J. R., Ilksoy N., You X., Belenkaya Y., Arrowood M. J., Fallon M. T., Schinazi R. F. Infection dynamics and clinical features of cryptosporidiosis in SCID mice. Infect Immun. 1994 May;62(5):1691–1695. doi: 10.1128/iai.62.5.1691-1695.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Moon H. W., Woode G. N., Ahrens F. A. Attempted chemoprophylaxis of cryptosporidiosis in calves. Vet Rec. 1982 Feb 20;110(8):181–181. doi: 10.1136/vr.110.8.181-a. [DOI] [PubMed] [Google Scholar]
  16. Moon H. W., Woodmansee D. B., Harp J. A., Abel S., Ungar B. L. Lacteal immunity to enteric cryptosporidiosis in mice: immune dams do not protect their suckling pups. Infect Immun. 1988 Mar;56(3):649–653. doi: 10.1128/iai.56.3.649-653.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rehg J. E., Hancock M. L., Woodmansee D. B. Characterization of a dexamethasone-treated rat model of cryptosporidial infection. J Infect Dis. 1988 Dec;158(6):1406–1407. doi: 10.1093/infdis/158.6.1406. [DOI] [PubMed] [Google Scholar]
  18. Rehg J. E., Hancock M. L., Woodmansee D. B. Characterization of cyclophosphamide-rat model of cryptosporidiosis. Infect Immun. 1987 Nov;55(11):2669–2674. doi: 10.1128/iai.55.11.2669-2674.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rossi P., Pozio E., Besse M. G., Gomez Morales M. A., La Rosa G. Experimental cryptosporidiosis in hamsters. J Clin Microbiol. 1990 Feb;28(2):356–357. doi: 10.1128/jcm.28.2.356-357.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sherwood D., Angus K. W., Snodgrass D. R., Tzipori S. Experimental cryptosporidiosis in laboratory mice. Infect Immun. 1982 Nov;38(2):471–475. doi: 10.1128/iai.38.2.471-475.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Solari A., Venegas J., Gonzalez E., Vasquez C. Detection and classification of Trypanosoma cruzi by DNA hybridization with nonradioactive probes. J Protozool. 1991 Nov-Dec;38(6):559–565. doi: 10.1111/j.1550-7408.1991.tb06080.x. [DOI] [PubMed] [Google Scholar]
  22. Tzipori S. R., Campbell I., Angus K. W. The therapeutic effect of 16 antimicrobial agents on Cryptosporidium infection in mice. Aust J Exp Biol Med Sci. 1982 Apr;60(Pt 2):187–190. doi: 10.1038/icb.1982.20. [DOI] [PubMed] [Google Scholar]
  23. Ungar B. L., Burris J. A., Quinn C. A., Finkelman F. D. New mouse models for chronic Cryptosporidium infection in immunodeficient hosts. Infect Immun. 1990 Apr;58(4):961–969. doi: 10.1128/iai.58.4.961-969.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Zhu G., McDougald L. R. Characterization in vitro and in vivo of resistance to ionophores in a strain of Eimeria tenella. J Parasitol. 1992 Dec;78(6):1067–1073. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES